| J0490 | Injection, belimumab, 10 mg | 1,240 | $2,880 | $3.6M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 21,540 | $90 | $1.9M |
| J0491 | Injection, anifrolumab-fnia, 1 mg | 290 | $4,250 | $1.2M |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 820 | $1,240 | $1M |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 6,440 | $80 | $482.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 660 | $500 | $326.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 1,980 | $120 | $243.8K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 1,270 | $150 | $194.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,260 | $60 | $133.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 50 | $2,030 | $109.3K |